CHBOF (China Health Technology Group Holding Co) ROCE %: 8.54% (As of Dec. 2025)


CHBOF China Health Technology Group Holding Co Ltd CHBOF
25 GF Score
Price $0.03
GF Value $0.07
! 7 Warning Signs
View Full Analysis

What is China Health Technology Group Holding Co ROCE %?

China Health Technology Group Holding Co CHBOF 25 ROCE % is 8.54% as of Dec. 2025. GuruFocus rates CHBOF with a GF Score™ of 25/100 and a GF Value™ of $0.07. The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. China Health Technology Group Holding Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 8.54%.

China Health Technology Group Holding Co  (OTCPK:CHBOF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

China Health Technology Group Holding Co ROCE % Related Terms

China Health Technology Group Holding Co ROCE % Historical Data

* Premium members only.

The historical data trend for China Health Technology Group Holding Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Technology Group Holding Co ROCE % Chart

China Health Technology Group Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.72 0.00 0.00 0.00 18.31

China Health Technology Group Holding Co Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2.76 9.55 27.03 8.54
CHBOF
25GF Score
China Health Technology Group Holding Co Ltd CHBOF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Health Technology Group Holding Co ROCE % Calculation

China Health Technology Group Holding Co's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=3.695/( ( (24.559 - 6.798) + (28.608 - 5.999) )/ 2 )
=3.695/( (17.761+22.609)/ 2 )
=3.695/20.185
=18.31 %

China Health Technology Group Holding Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=2.004/( ( (28.608 - 5.999) + (28.583 - 4.27) )/ 2 )
=2.004/( ( 22.609 + 24.313 )/ 2 )
=2.004/23.461
=8.54 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.54% mean?
China Health Technology Group Holding Co (CHBOF) has a ROCE % of 8.54% as of Dec. 2025.
Is China Health Technology Group Holding Co's ROCE % too high?
China Health Technology Group Holding Co's current ROCE % is 8.54%. The Forest Products industry median ROCE % is 3.38. China Health Technology Group Holding Co's value of 8.54% is 152.7% above this industry median. Overall, China Health Technology Group Holding Co has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's ROCE % compare to SSD and UFPI?
China Health Technology Group Holding Co's ROCE % of 8.54% can be compared against companies in the Forest Products industry. The industry median ROCE % is 3.38. China Health Technology Group Holding Co's value of 8.54% is 152.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Forest Products company?
The median ROCE % among Forest Products companies is 3.38, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Technology Group Holding Co's current ROCE % of 8.54% is 152.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Forest Products industry, the median ROCE % is 3.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Technology Group Holding Co's current ROCE % is 8.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current ROCE % of 8.54%. The stock's GF Value™ is $0.07, compared to a current price of $0.03 — trading 52.9% below its estimated fair value. The current ROCE % is 8.54% and 152.7% above the Forest Products industry median of 3.38. China Health Technology Group Holding Co's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current ROCE % is 8.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?

Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued. The current stock price of $0.03 is trading 52.9% below its estimated GF Value™ of $0.07.

Key valuation signals for CHBOF:

  • ROCE %: 8.54%
  • GF Value™: $0.07 vs. price of $0.03 (52.9% below fair value)
  • GF Score™: 25/100 with 7 warning signs
  • Industry Position: 152.7% above the Forest Products median

No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Health Technology Group Holding Co Business Description

Other Exchanges 01069:Hong Kong
Address South Binhe Avenue, Room 4903, Building A, West Tower, C Future City, Futian District, Shenzhen, CHN
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
25GF Score

Get the complete analysis for CHBOF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price
$0.07
GF Value